COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,088 Articles (22,658 medRxiv, 8,430 bioRxiv)

Most recent first Previous |  Page 2269: Articles 22681-22690  | Next

A Mental Health Paradox: Mental health was both a motivator and barrier to physical activity during the COVID-19 pandemic
Marashi, M. Y., Nicholson, E., Ogrodnik, M., Fenesi, B., Heisz, J. J.
10.1101/2020.09.03.280719 — Posted: 2020-09-03
The discovery of gene mutations making SARS-CoV-2 well adapted for humans: host-genome similarity analysis of 2594 genomes from China, the USA and Europe
Sun, W.
10.1101/2020.09.03.280727 — Posted: 2020-09-03
Phylo-geo-network and haplogroup analysis of 611 novel Coronavirus (nCov-2019) genomes from India
Laskar, R., Ali, S.
10.1101/2020.09.03.281774 — Posted: 2020-09-03
A Single Dose of Self-Transcribing and Replicating RNA Based SARS-CoV-2 Vaccine Produces Protective Adaptive Immunity In Mice
de Alwis, R. M., Gan, E. S., Chen, S., Leong, Y. S., Tan, H. C., Zhang, S. L., Yau, C., Matsuda, D., Allen, E., Hartman, P., Park, J., Alayyoubi, M., Bhaskaran, H., Dukanovic, A., Bao, B., Clemente, B., Vega, J., Roberts, S., Gonzalez, J. A., Sablad, M., Yelin, R., Taylor, W., Tachikawa, K., Parker, S., Karmali, P., Davis, J., Sullivan, S. M., Hughes, S. G., Chivukula, P., Ooi, E. E.
10.1101/2020.09.03.280446 — Posted: 2020-09-03 Discussion: Onsite
Boosting the analysis of protein interfaces with Multiple Interface String Alignment: illustration on the spikes of coronaviruses
Bereux, S., Delmas, B., Cazals, F.
10.1101/2020.09.03.281600 — Posted: 2020-09-03
Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies
Terry, J. S., Anderson, L. B., Scherman, M. S., McAlister, C. E., Perera, R., Schountz, T., Geiss, B. J.
10.1101/2020.09.03.280370 — Posted: 2020-09-03
Mutation in position of 32 (G>U) of S2M differentiate human SARS-CoV2 from Bat Coronavirus
Vahed, M., Vahed, M., Sweeney, A., Shirazi, F. H., Mirsaeidi, M.
10.1101/2020.09.02.280529 — Posted: 2020-09-03
Longitudinal single-cell immune profiling revealed distinct innate immune response in asymptomatic COVID-19 patients
Zhao, X.-N., You, Y., Wang, G.-L., Gao, H.-X., Cui, X.-M., Duan, L.-J., Zhang, S.-B., Wang, Y.-L., Yao, L., Li, L., Lu, J.-H., Wang, H.-B., Fan, J.-F., Zheng, H.-W., Dai, E.-H., Tian, L., Ma, M.-J.
10.1101/2020.09.02.276865 — Posted: 2020-09-03 Discussion: Onsite | Offsite
Impact of universal masking in health care and community on SARS-CoV-2 spread
Pletz, M. W., Steiner, A., Kesselmeier, M., Loeffler, B., Trommer, S., Weis, S., Maschmann, J., Stallmach, A.
10.1101/2020.09.02.20187021 — Posted: 2020-09-03
Vaccination for some childhood diseases may impact the outcome of covid-19 infections
Gobe, I., Koto, G. F., Molebatsi, K., Mokomane, M., Kasvosve, I., Motswaledi, M. S.
10.1101/2020.09.02.20186528 — Posted: 2020-09-03 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).